Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy is a San Francisco nonprofit created by former Napster and Facebook executive Sean Parker.

The Parker institute funds clinical trials for cancer treatments -- including for melanoma and pancreatic cancer -- and partners with cancer research centers, drug manufacturers and biotech companies to advance immunotherapy research. The institute was formed in 2016 with $250 million from the Parker Foundation.

Partners

  • Amgen
  • Apexigen
  • BD Biosciences
  • Breast Cancer Research Foundation
  • Bristol-Myers Squibb
  • Cancer Research Institute
  • Celldex Therapeutics
  • Clinakos
  • Curesearch for Children's Cancer
  • Emulate
  • Epinomics
  • Fluidigm
  • ImaginAb
  • Inovio Pharmaceuticals
  • Seres Therapeutics
  • Tempus
  • Tessa Therapeutics
  • Tmunity Therapeutics

Timeline

People

Name
Role
LinkedIn

Jeffrey Bluestone

President, CEO

Sean Parker

Chairman

Further reading

Title
Author
Link
Type
Date

Brainstorm Health: Pharma CEOs' Midterm Money, Parker Institute Investment, Merck Pfizer Combo Treatment

Sy Mukherjee

Web

Silicon Valley's Tech Elite Zoom in on Crispr

Megan Mo

News

Documentaries, videos and podcasts

Title
Date
Link

The Parker Institute for Cancer Immunotherapy: An Unprecedented Research Collaboration

November 15, 2016

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
TIME Staff
October 25, 2019
Time
A dozen novel ideas and technologies, from cancer-spotting AIs to pocket-sized ultrasound devices, that stand at the vanguard of medicine.
Hummingbird Bioscience
Invalid Date
www.prnewswire.com:443
SINGAPORE, Feb. 18, 2019 /PRNewswire/ -- Hummingbird Bioscience, a systems-biology enabled biotech company focused on the discovery and development of novel...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.